Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The association between Dementia, Overactive Bladder, and anticholinergic therapy in elderly patients
EF 2017-18
Résumé
One in five Canadians suffers from overactive bladder (OAB). OAB is characterized by having a frequent and urgent need to urinate, sometimes with incontinence and while sleeping. OAB causes significant distress for people, and is associated with depression and a poor overall quality of life. OAB is more common as people age, and can become a significant burden for older patients who have decreased mobility and cognitive abilities. OAB and urinary incontinence are one of the leading reasons for caregiver burnout in those looking after older family members. One of the initial treatments offered for OAB are anticholinergic medications which calm the bladder, thereby reducing bothersome symptoms. In Ontario alone, there are over 113,000 new users of bladder anticholinergic medications every year.This class of drugs is associated with undesirable side effects including confusion and decreased cognitive abilities. There is mounting concern amongst prescribers and patients that prolonged use of these medications puts patients at risk for dementia. With such concerns, patients and providers need to have a clear understanding of the cognitive risks associated with anticholinergic medication use in OAB.As such, our research aims to answer the question: Does the use of anticholinergic medications for OAB increase the risk of developing dementia? We will use province-wide health records from the past 20 years to address this question. This work will advance our knowledge of the medical management of urinary problems with ageing and will help us identify better therapies to treat OAB. With an ageing population in Canada, this problem represents an important public health issue.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386476
Name
Matta Rano
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The association between Dementia, Overactive Bladder, and anticholinergic therapy in elderly patients
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cholinergic Antagonists; Dementia; Geriatrics; Overactive; Pharmacoepidemiology; Urinary Bladder; Urinary Incontinence; Urogenital System; Urology
Abstract
One in five Canadians suffers from overactive bladder (OAB). OAB is characterized by having a frequent and urgent need to urinate, sometimes with incontinence and while sleeping. OAB causes significant distress for people, and is associated with depression and a poor overall quality of life. OAB is more common as people age, and can become a significant burden for older patients who have decreased mobility and cognitive abilities. OAB and urinary incontinence are one of the leading reasons for caregiver burnout in those looking after older family members. One of the initial treatments offered for OAB are anticholinergic medications which calm the bladder, thereby reducing bothersome symptoms. In Ontario alone, there are over 113,000 new users of bladder anticholinergic medications every year.This class of drugs is associated with undesirable side effects including confusion and decreased cognitive abilities. There is mounting concern amongst prescribers and patients that prolonged use of these medications puts patients at risk for dementia. With such concerns, patients and providers need to have a clear understanding of the cognitive risks associated with anticholinergic medication use in OAB.As such, our research aims to answer the question: Does the use of anticholinergic medications for OAB increase the risk of developing dementia? We will use province-wide health records from the past 20 years to address this question. This work will advance our knowledge of the medical management of urinary problems with ageing and will help us identify better therapies to treat OAB. With an ageing population in Canada, this problem represents an important public health issue.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Matta, Rano
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~